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People with alcohol and other drug problems are over-represented in the criminal justice system 
and prisons provide a unique opportunity to address these problems. 
The relationship between alcohol and other drug use and crime is complex and treatment in 
justice settings should reflect evidence-based practice, and target factors that are associated with 
criminal behaviour. 
It is important to address the needs of subpopulations of prisoners. These include women, 
Aboriginal and Torres Strait Islanders People, young adults, individuals with low literacy, those 
from diverse cultural and language backgrounds, and prisoners with co-occurring mental health 
issues or an acquired brain injury. 
Evidence of effectiveness is strong for: 
• Prison needle and syringe programs 
• Tailored cognitive behavioural therapy programs (both short- and long-term) 
• Individual counselling 
• Opioid substitution therapy 
• Therapeutic communities 
• Exit preparation programs (including pre-release centres) 
Evidence of effectiveness is moderate for: 
• Motivational interviewing 
• Therapeutic groups 
Evidence of effectiveness is insufficient for: 
• Peer educator programs 
• Contingency management 
• Twelve-step peer support groups, except as an adjunct to therapeutic interventions 
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Alcohol and other drugs 
and the justice system. 
 
The prevalence of alcohol and other drug use among people involved in the criminal justice 
system is significantly higher than the general population. 
Alcohol 
Risky alcohol use is highly prevalent among prison populations. In 2018, 34 per cent of Australian 
prison entrants reported consuming alcohol during the previous 12 months at levels that placed 
them at risk of alcohol-related harm.1  
Certain groups of prison entrants, such as offenders who are Aboriginal (46% vs. 26% of non-
Aboriginal prisoners) and male offenders (35% vs. 27% for females) are more likely to drink at risky 
levels. 
Illicit drugs 
Data from the 2018 National Prisoner Health Data Collection showed that 65 per cent of 
prisoners reported use of an illicit drug in the previous 12 months,1 compared to about 16 per 
cent of the general population in 2019.2 
National data from the 2020 Drug Use Monitoring in Australia program (DUMA) showed that 82 
per cent of police detainees tested positive to at least one drug that was not alcohol, and 46 per 
cent tested positive to more than one drug type.3 That finding was consistent with an earlier study 
which found one third reported using two or more drugs in the 30 days prior to being detained.4 
In 2018, 65 per cent of Australian prison entrants had used an illicit drug in the past 12 months, 
most commonly methamphetamine (43%) and cannabis (40%), followed by heroin (7%), cocaine 
(7%), and MDMA (5%). A further 10 per cent had used analgesics/pain killers, 8 per cent reported 




People who inject drugs 
Injecting drugs is more common among prison entrants than among the general population. A 
2013 survey found that 45 per cent of Australian prison entrants had injected drugs at some time 
in their lives, while 67 per cent of that group had used a drug by injection in the month prior to the 
survey.5 
Drug use also occurs during incarceration. According to the 2018 Health of Australian Prisoners 
Report, 16 per cent of a sample discharged from prison reported using illicit drugs whilst in 
prison, and 8 per cent reported using drugs by injection while in prison.1 
One study found that among a group of people who injected drugs and had a history of 
imprisonment, almost one-half had injected while in prison.6 
Alcohol and other drug use and offending 
The relationship between drug use and crime is complex, and the topic has generated a 
considerable body of literature over many decades.  
Alcohol and other drug use has been associated with a range of offences including those related 
directly to drug possession or sale; offences related to drug acquisition such as stealing; and 
offences related to lifestyle factors that predispose people who use drugs to engage in criminal 
activity.7 
While debates continue over whether alcohol and other drug use is a causal factor in criminal 
activity, evidence does show a relationship between levels of drug use and involvement in 
criminal activity.8 
Data from the DUMA program indicated that 46 per cent of all detainees surveyed in 2020 
reported that use of alcohol and/or drugs was a contributing factor to their most recent 
offending,3 which is consistent with international findings.9 Continued alcohol and other drug use, 
concurrent use in particular, has been shown to predict re-offending.10 
Different patterns of use have varying relationships with offending. A 2008 meta-analysis of thirty 
studies, predominantly US-based, found that the likelihood of offending was about three to four 
times greater for people who used drugs when compared to those who did not, and that the odds 
of offending varied across different alcohol and other drugs used: Six times higher for people who 
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used ‘crack’ cocaine, three times higher for people who used heroin, and one and a half times 
higher for people who used cannabis.11 
Implications for alcohol and other drug treatment  
Around half of all Australian prisoners are likely to meet the criteria for alcohol and other drug 
dependence.12 
Given the high prevalence of alcohol and other drug problems among people in Australian 
prisons and the relationship between alcohol and other drug use and its potential influence on re-




Effective alcohol and 
other drug interventions 
for people in prison. 
 
Alcohol and other drug intervention in prison 
Alcohol and other drug intervention within criminal justice settings should not only be delivered in 
accordance with the evidence base for effectiveness among the general population, but should 
also target factors that are associated with criminal behaviour, particularly the attitudes and 
beliefs that contribute to offending.7  
The risk-need-responsivity model  
In the criminal justice system, the main aim of any intervention is to stop the person from re-
offending. 
The risk-need-responsivity model is commonly applied, and relies on:  
1. assessment of risk of re-offending 
2. assessment of the factors that are associated with criminal behaviour (‘criminogenic needs’); 
and  
3. treatment being matched to the person’s assessed level of risk and needs that will result in 
the best positive outcomes (‘responsivity’).  
Criminogenic factors that are amenable to change -  referred to as ‘dynamic risk factors’ - are 
targeted by a matched type and dose of intervention.13 People with a higher risk of re-offending 
generally receive higher intensity interventions. 
Alcohol and other drug interventions  
Alcohol and other drug use is one of a range of dynamic risk factors open to change through 
evidence based treatment. Others include offending-related attitudes, beliefs and values; 




Addressing alcohol and other drug use by people in prison has been the subject of considerable 
investigation by researchers over the past two decades, and a number of informative and high-
quality systematic and non-systematic reviews have been published in the last ten years.  
Evidence-based treatment models that have been tested in a tightly controlled research context 
are often delivered differently in routine clinical practice. Although there may be practical reasons 
why facilitators of alcohol and other drug treatment programs adapt these effective treatments to 
suit a particular context or prisoner group, research shows that the most effective programs are 
those that are delivered as originally intended.14  
Screening and assessment 
Accurate screening and assessment are crucial components of effective alcohol and other drug 
treatment in custodial settings. 
The purpose of screening is to identify the possible presence of an alcohol and other drug use 
problem to determine whether a detailed assessment is needed.15 
Evidence-based screening tools that are sufficiently sensitive to detect a problem, and able to 
detect a specific problem (e.g. alcohol, cannabis, methamphetamine) are frequently used. They 
can reduce unnecessary referrals for comprehensive assessment.15, 16 
Screening tools may be clinician administered, but many are suitable for self-completion.  
Screening should be conducted as early as possible after entry into the justice system.17 
If alcohol and other drug use problems are detected through screening, an assessment to 
determine the nature and extent of a person’s drug problem is then conducted. The assessment 
should be comprehensive and allow people to be appropriately matched with an alcohol and 
other drug program that is likely to meet their needs. 
Assessments that rely on broad definitions of ‘drug use problems’ are a key barrier to effective 
treatment matching. 
Identification of alcohol and other drug problems through screening can improve outcomes for 




Modelling of alcohol and other drug screening and treatment for opioid use disorder in the US 
identified that 1,840 lives could have been saved in 2016 with wide scale uptake of screening and 
treatment in the prison system, and that approximately 4,400 lives could have been saved with 
screening, treatment, and post-release treatment retention.18   
Mental health symptoms should also be assessed during at intake due to the high level of co-
occurrence between alcohol and other drug and mental health problems in Australia.7, 16 
Repeat screening and assessment is also recommended for offenders, as readiness for alcohol 
and other drug treatment and fear of disclosing alcohol and other drug use is likely to change 
over time.17 
Harm reduction programs 
Prison based alcohol and other drug programs are designed to improve alcohol and other drug 
related health concerns as well as to address use. 
People in custody have disproportionately high rates of blood borne viruses such as hepatitis C 
virus (HCV), often related to their alcohol or other drug use.19, 20 
Alcohol and other drug treatment planning that includes strategies to prevent and treat serious, 
chronic medical conditions, such as HIV/AIDS, hepatitis B and C, and tuberculosis is a key 
principle of practice for working with offenders who use alcohol and other drugs.7 
Harm reduction strategies aim to directly reduce the harms associated with illicit drug use for 
individuals, families and communities, without necessarily reducing drug consumption.  
Strategies can include harm reduction education, needle and syringe programs, blood-borne 
virus testing and hepatitis vaccination, provision of condoms and dental dams, and access to 
methadone treatment.21 
Harm reduction interventions for high-risk behaviours like needle-sharing and unprotected sex 
reduce the spread of infectious diseases.7 
Needle and syringe programs 
Needle and syringe programs (NSPs) are an evidence-based community harm reduction 
intervention. They provide clean injecting equipment to people who inject drugs, which has been 
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shown to effectively reduce injecting risk 
behaviours22 and reduce the spread of blood 
borne viruses.23, 24 
Strong evidence in Australia and internationally 
has shown that the use of non-sterile injecting 
equipment in prisons is associated with extensive 
HIV transmission.19 
It is estimated that only around 60 prisons out of 
more than 10,000 worldwide have implemented 
NSPs.25 The benefits are clear despite limited 
implementation. They reduce the rate of blood-
borne viral transmission among prisoners who inject drugs and improve referral to, and uptake of, 
appropriate treatment among prisoners with drug dependence.26-30 
Models of delivery include anonymous syringe dispensing machines, direct distribution by prison 
health staff and/or non-government organisation workers, and distribution by prisoners trained as 
peer outreach workers. Despite concerns, prison based NSPs have not resulted in serious, 
unintended negative consequences.19  
The ACT was the first state or territory to incorporate the potential for a prison-based NSP into 
Government policy. No prison-based NSPs operate in Australia. 
Peer educator programs 
Peer education programs in alcohol and other drug treatment services utilise trained peers (i.e. 
people who have in the past, or currently use alcohol and other drug), to provide targeted drug-
related harm reduction and health promotion information relevant to the needs of a specific 
group.  
The aim of peer education is to actively share harm reduction information via a perceived credible 




Outside of prison, community peer-education is effective at reducing harms associated with 
injecting drug use.31 Peer educators also benefit from implementing education, as they gain 
knowledge, enhance self-esteem, and reduce their own risky behaviours.32 
There is limited research on the efficacy of prisoner peer education approaches specific to 
alcohol and other drug use. One qualitative study of alcohol and other drug group treatment 
reported that programs facilitated by individuals with personal experience of alcohol and other 
drug use disorder were seen as advantageous.33 
There is evidence demonstrating the effectiveness of peer-led education in prisons for related 
issues. A systematic review concluded that in-prison peer education programs achieve similar 
results to those conducted in the community.34 
Peer-led HIV education programs have been shown to be effective in reducing sexual and drug 
taking risk behaviours post-release including not using a condom at first intercourse after release 
from prison, injecting drugs, past month injection, and sharing injection equipment.34, 35 
A small number of studies have consistently shown that peer educators are as effective as 
professional educators in HIV prevention. Peer educators also improve their own knowledge of 
health issues as a result of their training.34 
One study examined a mentoring and case management program developed for incarcerated 
women with co-occurring mental health issues and alcohol and other drug use re-entering the 
community.36 The study provided weak evidence that peer mentoring, rather than peer education, 
reduced alcohol and other drug use and re-offending, and had positive effects on health 
behaviours and treatment adherence.34 
Detailed examples of effective interventions may guide program development. In a trial of harm 
reduction peer education among incarcerated men,37 overall positive outcomes were observed in 
reductions in alcohol and other drug use, sexual risk taking and health self-efficacy across four 
interventions provided as part of a pre-release and community re-entry program: 1) an 
educational and skills building program on HIV and alcohol and other drug use delivered by an 
ex-prisoner who is HIV-positive; 2) the program as delivered by an HIV-negative peer facilitator; 3) 
a non-peer facilitator; and 4) presentation of health promotion and disease prevention videos. 
However, peer education groups, particularly those led by an HIV-positive facilitator, showed 
significantly greater changes in alcohol and other drug use at three-month follow-up post-release. 
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All interventions were implemented in a 12-session curriculum, two groups per week over six 
weeks. The peer education interventions included goal setting, skills-building, role playing and 
discussion activities. Facilitators used their own personal experiences to demonstrate skills and 
information.37 
Length and intensity of training for peer educators programs vary greatly, and depend on factors 
such as the program content and mode of delivery.35 In a community setting, a randomised 
controlled trial demonstrated that a six-session, small-group, cognitive behavioural, skills-building 
intervention to teach peer education skills to young injecting drug users, reduced the educators’ 
injection risk behaviours.32 
In prison settings, some HIV peer education programs have conducted training for peer educators 
as intensive courses, such as 40 hours over one week. These courses have shown promising 
evidence of effectiveness.38, 39 
Medication-assisted treatment of opioid dependence 
Medication assisted treatment of opioid dependence (MATOD) is associated with reductions in 
drug use and to some extent, criminal activity among offenders.40-42 People with opioid 
dependence are overrepresented in the justice system and are at higher risk of mortality.43 
The immediate post-release period is often a time of high risk for overdose among offenders 
whose tolerance to opioids has largely diminished.44 MATOD administered to people in prisons is 
associated with reduced mortality at four year follow up, both in prison and in the community.41,45 
People who receive continued access to methadone during incarceration report less use of 
heroin, fewer non-fatal overdoses, and increased retention in treatment 12 months post-release 
compared with people not receiving methadone immediately prior to release.46 
Psychosocial interventions such as cognitive behavioural therapy (CBT) and contingency 
management delivered concurrently can enhance the effectiveness of MATOD.47 MATOD has 
been available in Victorian prisons since 2003 and the demand for treatment is reportedly high.48  
Prisoners receiving MATOD are less likely to receive disciplinary tickets while incarcerated and 
are more likely to engage with community MATOD providers after release. Among those 
receiving post-release MATOD from the prison provider, there is reduced risk of arrest, new 
charges and re-incarceration compared to those who do not re-engage with MATOD.49 
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Findings from a New South Wales  longitudinal cohort study found that for people who left prison 
on methadone and remained in MATOD, there was a 20 per cent reduction in re-incarceration 
during the nine years observation period.50 These findings were echoed in a systematic review of 
opioid interventions among people in prison, which found engagement with MATOD reduced the 
likelihood of reincarceration and improved the likelihood of employment  one year post-release.51  
A broader systematic review of MATOD in prisons, which included experimental and 
observational studies, concluded that MATOD commenced pre-release was associated with 
reduced heroin use, reduced injecting and sharing of syringes when doses were adequate, and 
with increased treatment entry and retention after release.52  
Importantly, disruption of MATOD continuity, especially due to brief periods of imprisonment, was 
associated with significant increases in incidence of HCV.52 
An analysis of 14 randomised control trials (RCTs) found that methadone, in particular, had no 
impact on recidivism outcomes (arrest, conviction, charges, re-incarceration), while treatment 
with antagonists (such as naltrexone) did reduce criminal activity.53 Similar outcomes for 
methadone treatment were reported in a meta-analysis, where methadone did not reduce 
recidivism.49  
Intensive interventions 
Behavioural and cognitive therapies 
CBT specifically targets unhelpful thinking and behaviours and is a cornerstone of evidence-
based alcohol and other drug treatment. 
Cognitive behavioural approaches include self-monitoring, goal setting, interpersonal skills 
training, relapse prevention, and lifestyle modification. There is considerable evidence for the 
effectiveness of well-conducted CBT on reducing recidivism among offenders and general prison 
populations.9, 54, 55 
A systematic review and meta-analysis conducted by Lipsey and colleagues in 2007 included 58 
studies of CBT treatment with offenders (including 27 studies of treatment based in correctional 
institutions).54 CBT was as effective in reducing recidivism among offenders in prison as it was for 
offenders in the community. 
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CBT increased the likelihood that participants would not re-offend in the 12 months after 
discharge by 1.5 times when compared to controls, resulting in an overall reduction in recidivism 
of 25 per cent.  
While the review included a range of CBT programs, not exclusively focused on alcohol and other 
drug use, it provided indicators of effective CBT for offenders that appear generalisable to 
prisoners with alcohol and other drug use problems. 
CBT programs are variable. Some are delivered over 5-10 weeks and others over 6 months during 
residential treatment.  
Program intensity (number of CBT program sessions and to a lesser extent the number of contact 
hours per week) was a better predictor of reduced recidivism. Those at highest risk of re-
offending received the greatest benefit. 
Lipsey et al.54 concluded that the CBT approach was responsible for the overall effects on 
recidivism, regardless of variable program lengths. They concluded that several key factors were 
related to the greatest effect sizes:  
• Inclusion of distinct anger control and cognitive restructuring components in the CBT 
program enhanced the effects, while victim impact components appeared to diminish effects 
• High quality implementation reflected by close monitoring of the quality and fidelity of 
treatment delivery (delivering the program as intended) 
• Adequate CBT training for the providers 
• The addition of individual therapy to group therapy. 
A review of the literature on effective alcohol and other drug treatment programs for offenders 
highlighted the efficacy of CBT in prison.9 The review identified two evaluation studies of CBT 
programs within intensive prison residential programs of at least six months’ duration and that 
applied four hours of treatment programming each week day. This demonstrated greater 
reductions in drug use and recidivism among people who had been in prison who had received 
CBT at between six- and 12-months post-release. 
One of these studies evaluated the ‘Forever Free’ six-month program for female prisoners that 
operated as a modified therapeutic community with a cognitive-behavioural curriculum and 
relapse prevention focus.56 Program elements included individual alcohol and other drug 
counselling, educational seminars, 12-step programs, parole planning and individual and group 
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sessions on issues specific to supporting women such as assertiveness training, relationships, 
trauma, and parenting skills.  
The second of these studies evaluated 20 residential unit-based alcohol and other drug treatment 
programs, based on a cognitive-behavioural model with relapse prevention approach as a core 
element. 57, 58 Most programs were delivered as a ‘moderate’ intensity 500-hour treatment 
program over nine months, with 1 staff member for every 24 participants. 
Three of the programs were ‘high’ intensity treatment units involving 1000 hours of treatment 
over 12 months and staff ratio of 1:12 participants.58 Psychoeducation and group process 
treatment was generally conducted for a half-day in two consecutive 2-hour sessions five days 
per week. Group sessions involved 10 to 12 participants on topics such as cognitive skills 
building, relapse prevention, interpersonal skills building and criminal lifestyle examination, with 
some availability of individual counselling.  
Including contingency management strategies, incentives for participation were included and 
ranged widely from small items such as pens up to reduced sentence length for non-violent 
offenders successfully completing the program.57 
People who entered and completed in-prison residential drug and alcohol treatment were less 
likely to experience new arrests and alcohol and other drug use in the first six months following 
release, which reflects positive results across multiple sites of varied security levels and with both 
women and men in prison, and the potential for replicating the CBT approach in other settings.58 
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A systematic review aimed to identify the most 
effective treatment for alcohol and other drug use 
among men in prison. A review of papers between 
1995 and 2015 suggested that CBT delivered in a 
therapeutic community setting was best practice 
in alcohol and other drug treatment in prisons.59 
Australian CBT programs  
An evaluation of intensive offender programs in 
three New South Wales custodial settings reflects 
the effectiveness of the CBT model. CBT 
components were at the core of these intensive 
residential treatment programs that ranged from 
three to 12 months duration.60 All programs implemented group-based CBT using either the 
‘Pathways’ intensive program (100 hours) and/or ‘Getting SMART’ 12-session program. 
The evaluation found treatment program completers achieved relatively reduced rates of 
recidivism in the short-to medium term post-release (6 to 12 months), rates of offences in custody 
declined among program completers, and program completers were half as likely as non-
completers to be charged with a drug offence while in custody.60 
The ‘Pathways’ program, also known as ‘Criminal Conduct and Substance Abuse Treatment: 
Strategies for Self-Improvement and Change – Pathways to Responsible Living’ is applied in 
various forms in prisons in Queensland, Western Australia, New South Wales, ACT and 
Tasmania.61 
It is a high intensity CBT program that addresses the link between criminal behaviours and 
alcohol and other drug use. In Australian programs it generally involves at least 100 hours of 
treatment delivered over 16 to 21 weeks (e.g. three two-hour sessions per week).61-63 
There is some indication that involvement in and/or completion of programs utilising the 
‘Pathway’ model can positively affect an individual’s understanding of their criminal behaviours 
and ability to manage cravings,64 and may be associated with reduced rates of recidivism.65  
However, evaluations of the Pathways program are influenced by methodological issues, such as 
such as short-term follow-up and/or involving small samples of people in prison.64, 65 
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Shorter-term CBT programs  
Shorter-term CBT programs are also effective.9 Studies of specific intervention programs ranging 
from eight to 16 weeks duration show positive alcohol and other drug use outcomes, such as 
increased abstinence.9 
Program approaches that appear to be aligned with effective CBT treatment for alcohol and other 
drug use in general populations include the ‘Getting SMART’ 12-session CBT group intervention 
(18-24 hours). The program is the most commonly delivered program in the New South Wales 
corrections system and aims to reduce risk of re-offending by addressing alcohol and other drug 
use. It also aims to motivate and facilitate involvement in ongoing SMART Recovery meetings.60, 66  
Findings from 39 Getting SMART programs across six New South Wales custodial sites in 2007-
2008 showed high completion rates (83% of participating prisoners). 66 However, motivation to 
complete the program was strongly linked to the knowledge that participation in programs could 
improve the likelihood of progress to parole. 
There is some promising evidence for short-term, but intensive, CBT interventions. Bahr et al. 67 
compared outcomes for people in prison who received an intensive, short-term CBT program (the 
OUT Program) with a matched sample who did not participate in the program. The program 
focused on skill building, providing life-skills training, cognitive distortion awareness, and 
therapeutic interventions.  
The 30-day intervention was delivered as an intensive reintegration preparation program and 
involved 100 hours of treatment, delivered five days per week over four weeks. The authors noted 
high intensity treatment has previously been categorised as programs with more than 3.3 hours 
per week.67 
Study participants were followed up 14 months after release. Those who participated in the 
treatment program were significantly less likely to have returned to prison for more than 30 days 
compared with those who did not participate (27% vs 46%) and reported overall reduced rates of 
any re-arrest (49% compared to 63% of control group). 
Mindfulness Based Relapse Prevention 
Mindfulness based interventions for alcohol and other drug problems comprise a range of 
treatments and approaches , which have been developed to target relapse and improve alcohol 
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and other drug treatment outcomes. Mindfulness based interventions form part of the suite of 
cognitive and behavioural therapies.  These interventions involve intentional and sustained focus 
of attention on present moment experiences, with an attitude of acceptance, non-judgment, and 
curiosity.68, 69 
Mindfulness based interventions may be almost wholly based on principles of mindfulness and 
mindfulness meditation practice, such as mindfulness-based cognitive therapy (MBCT). Or, like 
dialectical behaviour therapy (DBT) and Acceptance and Commitment Therapy (ACT), combine 
mindfulness techniques with other therapeutic approaches.68 
Mindfulness based relapse prevention (MBRP) integrates secular mindfulness meditation 
practices with traditional cognitive behavioural relapse prevention techniques, such as 
identification of individual risk factors and triggers and improving coping skills. MBRP was 
designed as an outpatient therapeutic group program.70 
Studies of mindfulness based meditation approaches for alcohol and other drug problems, 
including among incarcerated populations69, 71 and a number of randomised controlled trials into 
the effectiveness of MBRP for offenders72, 73 provide promising evidence of its efficacy. 
However, systematic reviews, which included two trials of MBRP in prison settings, found that 
there was limited high quality evidence available on the effects of MBRP and additional studies are 
required.74, 75 
Contingency management 
Contingency management is a behavioural therapy that is underpinned by the premise that 
reinforcing ‘non-drug using’ or ‘desirable’ behaviours should decrease drug use.76 
Contingency management involves the provision of rewards to reinforce treatment goals, such as 
attendance and participation in therapy and/or pharmacotherapy, and alcohol and other drug 
abstinence. The most common method of contingency management in prisons involves the use 
of tokens or points. These tokens or points can be ‘earned’ for good behaviour or treatment 
adherence and can be redeemed for material goods or access to recreational activities.77 




Contingency management is compatible with strategies used in many criminal justice settings, in 
which reinforcements and sanctions are routinely used. It is also being implemented to support 
alcohol and other drug treatment and compliance goals in settings like drug courts and probation 
agencies.78,79 
The evidence-base for use in these settings is still developing. Its effectiveness in prison alcohol 
and other drug treatment programs is not clear; however, ‘contingency contracting’ is considered 
an important element of the compulsory drug treatment programs.80 
Motivational interviewing 
Motivational interviewing is an approach that emerged from a humanistic framework in response 
to traditional confrontational approaches commonly used in alcohol and other drug treatment.81 
The approach is focused on increasing a person’s readiness to change. Strategies to increase 
motivation include exploring ambivalence about alcohol and other drug use and highlighting 
discrepancy between current alcohol and other drug use and the person’s goals for the future. A 
growing body of evidence supports the effectiveness of motivational interviewing with people 
who use alcohol and other drugs.82 
A 2009 systematic review examined the effectiveness of motivational interviewing with offenders 
and, though outcomes varied across studies, motivational interviewing was associated with 
reduced offending, improved retention in treatment and enhanced motivation to change.83 
Another review found motivational interviewing had positive effects on alcohol and other drug 
use outcomes among people convicted for the first time of driving under the influence of alcohol 
and in detention; incarcerated adolescents with depressed mood; and women with risky patterns 
of alcohol and other drug use.84 It involved an in-reach alcohol screening and motivational 
interviewing intervention with women in prison using the Alcohol Use Disorder Identification 
Test-Including Drugs tool (AUDIT-12) and provision of personalised feedback on screening 
results using a brief motivational interview format.85 
There was significantly greater improvement in alcohol and other alcohol and other drug use 
screening results at two months’ post-release among women randomly assigned to the 




Therapeutic groups  
Almost all prison-based alcohol and other drug programs are delivered in a group setting. A 
review of health interventions for prisoners found that psychotherapy group interventions 
achieved positive alcohol and other drug use outcomes in studies of Acceptance and 
Commitment Therapy, group interventions for women prisoners, and in male and female prison-
based modified therapeutic communities.84 
Group programs appear most effective when they are targeted towards single gender groups 
and are engaged in voluntarily.86 
Individual counselling 
Individual counselling significantly improves the impact of CBT group-based rehabilitation 
programs on recidivism outcomes among the general prison population.54 It is likely that this 
finding is applicable to alcohol and other drug specific CBT programs.  
Programs defined as ‘group counselling’ for people in prison in the literature may also include 
elements of individual counselling. Such programs are effective at reducing offending.86 
Effective approaches often utilise combinations of modalities and include individual counselling 
with group CBT programs. For example, the Canadian Offender Substance Abuse Pre-release 
Program (OSAPP) delivered 26 three-hour group sessions plus three individual counselling 
sessions to people in prison with moderate to severe alcohol and other drug problems.12, 55 
The program demonstrated good completion rates (89%) and lower recidivism among program 
completers: 42 per cent of completers were imprisoned again in the follow-up period compared 
with nearly 49 per cent of matched comparison offenders. 
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Exit preparation programs 
Programs that prepare people in prison with alcohol and other drug problems for transition into 
the community vary widely. 
A number of evidence-based approaches, such as CBT and motivational interviewing, are 
delivered in prisons to support re-integration into the community, to facilitate engagement with 
treatment, and reduce relapse to alcohol and other drug use and/or reoffending.  
An intensive 30-day CBT program for people in prison with alcohol and other drug problems who 
were serving short sentences was designed to prepare participants for re-integration into the 
community. Program participants spent five hours per day in treatment, five days per week for 
four weeks, equating to 100 treatment hours.  
The program was associated with significantly lower recidivism: 27 per cent of the treatment 
participants returned to prison for more than 30 days, compared with 46 per cent of a matched 
comparison non-treatment group.67 
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A study among women with alcohol and other drug problems examined the effect of a prison in-
reach brief screening and feedback intervention, which included use of motivational interviewing 
for those with risky patterns of alcohol and other drug use.85 There was a significantly greater 
reduction in alcohol use two-months post-release among women randomly assigned to the 
intervention compared with those not receiving the intervention. Recidivism was not measured in 
the short follow-up period. 
Continuity of care post-release is essential for maintaining the benefits of in-prison psychological 
intervention. While several studies have reported the benefits of psychological intervention while 
in prison on recidivism, one systematic review and meta-analysis demonstrated that the benefits 
observed are likely explained by publication bias and small-study effect size.87 Benefits are no 
longer observed when only studies with large cohorts (! 50 participants) are included in analyses. 
Therapeutic communities post-release were associated with decreased rates of recidivism, which 
demonstrates the importance of sustained care for people in prison after release. 
Pre-release centres 
Pre-release centres are a specialised form of exit preparation program. Pre-release centres 
operate in a number of states, including New South Wales, South Australia, Western Australia 
and the Australian Capital Territory.64 
In New South Wales, female offenders with alcohol and other drug problems who participated in 
the specially designated pre-release Bolwara Transitional Centre, showed consistently lower 
rates of recidivism compared to a matched control group at 6, 12 and 24 months after release.60 
Bolwara was separated from the main correctional complex and provided support for women 
with histories of alcohol and other drug use problems and included specialised services for 
Aboriginal participants provided on site and in the community, including a ‘Koori women’s group. 
After controlling for other risk factors, the study reported Bolwara Transitional Centre participants 
were around 30 per cent less likely to re-offend and return to custody for a new offence.60 
Therapeutic communities 
Prison-based therapeutic communities are therapeutic communities that have been modified to 




A comparatively large evidence base shows mixed outcomes, but the therapeutic communities 
are widely considered to be an effective treatment for people in prison with alcohol and other 
drug problems, demonstrating relatively consistent reductions in recidivism and alcohol and other 
drug use.9, 12, 86 
A systematic review reported on 14 studies focused solely on examining the effectiveness of 
therapeutic communities among people in prison who were alcohol and other drug dependence 
at the time of initial imprisonment.88 
Three-quarters of the studies showed therapeutic communities were effective in reducing rates 
of re-imprisonment; seven of the nine studies that examined alcohol and other drug relapse found 
the intervention to be effective in reducing rates of relapse; and five of the nine studies reported 
that therapeutic community participation reduced re-arrest. 
From four studies, including results at longer-term follow up periods of two or more years, overall 
results suggest that treatment gains may taper over the longer-term.  
Overall, across three main outcome areas, therapeutic communities were shown to have 
produced the greatest effect on reducing re-imprisonment, reducing alcohol and other drug 
relapse, and reducing rates of re-arrest than other treatment alternatives. These effects were 
irrespective of aftercare or type of therapeutic community applied, though the combination of 
therapeutic community with aftercare programs may increase reductions of re-imprisonment and 
drug use.88 
In contrast, one RCT examined the effects of treatment modality (therapeutic groups vs. 
therapeutic communities) on re-imprisonment rates among 604 people leaving prison over a 
three-year follow-up period.89 
The study demonstrated that the superiority of prison therapeutic community to less intensive 
group counselling (total of 150 hours’ treatment) was not fully supported; TC resulted in 
significantly reduced likelihood of re-imprisonment; however, differences between the 
interventions’ effects on reducing re-arrest and drug relapse were not significant. 
The investigators also explored the relationship between risk of reoffending characteristics and 
alcohol and other drug program type and found that not all people considered high risk 
responded positively to a therapeutic community environment. 
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The authors concluded that the most intensive intervention may not always be the most 
appropriate for high-risk offenders and suggested that other factors that affect response to 
treatment must be considered including negative affect, cognitive limitations, interpersonal skills, 
and prior treatment when conducting treatment matching.  
Twelve-step peer support groups 
Twelve step groups such as Alcoholics Anonymous (AA) and Narcotics Anonymous (NA) are 
often used to complement alcohol and other drug interventions but are not considered 
therapeutic treatments in their own right.  
Studies have shown that AA attendance is associated with reduced alcohol use and symptoms of 
dependence, and NA and Cocaine Anonymous attendance are associated with positive 
outcomes such as greater rates of abstinence.90, 91 
Participation in these support groups, particularly after completing a treatment program, can 
significantly reduce relapse after treatment, result in longer periods of ongoing abstinence than 
treatment alone, and help improve social functioning of people who are focused on maintaining 
changes to their alcohol and other drug use. 90 
While many custodial settings provide access to 12-step groups, in particular AA and NA, there is 
limited research concerning its effectiveness in prison settings.86 
An earlier review and meta-analysis from 1999 concluded that while quality evaluations were 
lacking, 12-step groups were widely used as adjunct to other programs and were considered 





People in prison with 
specific needs. 
 
Some subpopulations of people in prison have 
specific needs that require attention during 
alcohol and other drug treatment. 
Women 
The profile of women involved in the criminal 
justice system differs from their male 
counterparts. Women have complex needs 
related to increased risk of exposure to 
victimisation, trauma and abuse; high rates of 
mental and physical health problems; primary 
parenting responsibilities; and issues with other relationships.93 
Women in prison may also experience greater severity of alcohol and other drug dependence 
than men.94 Australian studies have reported different alcohol and other drug use patterns, 
including greater use of heroin, analgesics and sedatives among women in prison compared to 
men in prison.20, 95 
Alcohol and other drug use problems among women represent ‘an acute dynamic risk factor’ that 
had an immediate association with offending behaviours.96 
While much is known about effective treatments for male offenders, interventions for women 
offenders has been subject to less investigation, and the variation in methodology among studies 
is a barrier to drawing firm conclusions about the effectiveness of these programs.97 
Nevertheless, effective alcohol and other drug treatment can reduce women offenders’ 
involvement with the criminal justice system and decrease their risk of re-offending,98, 99 and 




One study found that women who participated in alcohol and other drug treatment whilst in 
prison were less likely to reoffend than those who did not participate, and overall positive 
outcomes were found on measures of mental health and alcohol and other drug use.99 Large 
effect sizes were linked to interventions that applied CBT, group trauma therapy and 
psychoeducation, and these interventions were found to reduce symptoms of anxiety, depression 
and trauma.  
Researchers Hall et al.100 recommended that interventions should comprehensively address 
psychological and social needs of women such as victimisation, alcohol and other drug use and 
other mental disorders to increase the effectiveness of standard alcohol and other drug treatment 
programs.100 
When evidence based alcohol and other drug treatment is also gender sensitive (for example, 
treatment encompassing women’s experience of trauma, influences of their relationships, role 
and parenting responsibilities) in criminal justice settings it has been shown to reduce drug use 
and criminal behaviour.98, 101 
A Cochrane review also found gender responsive treatment, as well as TCs, to be associated with 
a reduction in re-imprisonment rates for women offenders with alcohol and other drug 
problems.97  
Studies have also shown that a longer duration of program is not always the best option. For 
example, a 2014 study with women in prison experiencing co-occurring mental health and 
alcohol and other drug use disorders receiving prison based treatment reported greater 
‘misconduct’ was associated with treatment over 90 days, and ‘misconduct’ further increased 
based on exposure to more than 180 days of treatment.102 This finding is contrary to the general 
understanding that longer time in treatment is associated with better outcomes and suggests 
optimal treatment time for some client groups may be shorter than expected. 
Like their male counterparts, aftercare programs for women offenders post-release are important 
for maintaining treatment gains.94 Aftercare is associated with reduced risk of recidivism, 
especially when combined with treatment that was initiated while women were in prison.103 
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Aboriginal and Torres Strait Islander People 
Aboriginal and Torres Strait Islander People are over-represented in Australian prisons. The 
National Drug Strategy 2017-2026 highlights both Aboriginal and Torres Strait Islander People 
and people involved with the criminal justice system as priorities for harm reduction.104 
Aboriginal and Torres Strait Islander People have a number of culturally specific criminogenic 
needs in alcohol and other drug treatment that include acculturation stress and de-culturation; 
separation from family, communities and land; physical and mental health problems; violence; 
discrimination; literacy and numeracy problems; generational unemployment; and significant and 
specific transitional and post-release needs.105, 106 
The National Indigenous Drug and Alcohol Committee note that alcohol and other drug use 
issues experienced by incarcerated Aboriginal and Torres Strait Islander offenders include 
transmission of blood-borne viruses, and comorbidity of mental health and alcohol and other drug 
use issues, which is a significant factor in Aboriginal and Torres Strait Islander offenders’ over-
representation in the criminal justice system. 
Alcohol, in particular, is a common precursor to offending, and Aboriginal offenders are 
significantly more likely to report being under the influence of alcohol at the time of the offence or 
arrest than non-Aboriginal Australian offenders.106, 107 
While imprisoned, issues such as separation from family and culture, and previous history of an 
undiagnosed or untreated health condition can increase risk of harms for Aboriginal and Torres 
Strait Islander People.  
Involvement with the criminal justice system may provide opportunities to provide interventions to 
improve the general health of the person while imprisoned.106, 108 
Aboriginal and Torres Strait Islander People in prison are more likely to use health services when 
in prison than in the community, although access to in-prison treatment programs has been 
found to be particularly limited among Aboriginal and Torres Strait Islander People. 
A study with Koori people in prison in Victoria found that barriers to accessing treatment included 
feelings of mistrust, lack of cross cultural awareness and stigma, in particular in relation to blood 
borne viruses and sexually transmitted infections.108   
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Empirical research identifying effective treatment approaches specifically for Aboriginal and 
Torres Strait Islander offenders is lacking; however, a range of studies and treatment manuals can 
inform the development and delivery of alcohol and other drug treatment for Aboriginal and 
Torres Strait Islander more broadly. 
General recommendations for working with Aboriginal people with alcohol and other drug 
problems emphasise collaborative, culturally sensitive, strengths-based and family inclusive 
approaches, including involvement of trained Aboriginal workers and the use of culturally specific 
written materials.105-107, 109, 110 
Treatment delivery should be culturally specific, that is, delivered within a framework of cultural 
competence, in which respect for Aboriginal people’s culture is recognised, respected, and 
safeguarded; cultural safety that ensures an environment for Aboriginal people that is free from 
‘assault, challenge, or denial of a person’s identity’; and cultural security in which cultural values 
are actively incorporated into the planning, delivery and evaluation of treatment practice.111 
Dolan and colleagues noted that from the limited evidence available, culturally specific alcohol 
and other drug treatment for marginalised populations are required to improve engagement with 
alcohol and other drug treatment in both prison and the community; however, there was a paucity 
of research available to guide the development of such programs. In 2009, there were seven 
Aboriginal specific programs provided by external organisations in four states.108 
An evaluation of three intensive alcohol and other drug programs in New South Wales custodial 
centres found that Aboriginal and Torres Strait Islander participants showed higher completion 
rates than non-Aboriginal offenders (75% vs. 63%).60 
Program graduates showed a lower rate of in-prison alcohol and other drug use than non-
graduates, and improvements in health-enhancing attitudes and behaviours such as motivation 
to change. 
Two programs were delivered in designated wings. For example, the Bolwara Transitional Centre 
was a separately located pre-release program for female offenders that included specialised 




People with co-occurring mental health problems 
The prevalence of mental health problems among people in prison in Australia is high. In 2012, 
21per cent of Australian prison entrants were currently taking medication for a mental health 
disorder and 15 per cent reported very high levels of emotional distress.20 
International studies have found that compared to the wider community, people in prison were 
several times more likely to have psychosis or major depression, and ten times more likely to have 
an antisocial personality disorder.53 
In Australia it is estimated that about eight per cent of men in prison and 14 per cent of women in 
prison had a major mental disorder with psychotic features, compared to less than one per cent 
of the general population.112 
Little is known about evidence-based alcohol and other drug treatment specifically for people in 
prison with concurrent mental health problems. A Cochrane review of interventions for offenders 
with co-occurring alcohol and other drug problems and mental illness assessed evidence of drug 
use and/or criminal activity outcomes, while mental health and wellbeing outcomes are intended 
to be included in future reviews.113 
The review concluded that two trials of therapeutic communities and aftercare showed 
promising results for reducing re-imprisonment among this group. However, with only two 
studies available, the wider applicability of the finding is somewhat limited.  
Across studies, the therapeutic community model showed less success in reducing rates of re-
arrest and limited or mixed findings about reducing self-reported drug use.  
While trials of therapeutic communities showed 
mixed findings, one randomised trial that involved 
a 12 month prison-based modified therapeutic 
community with the option of six months voluntary 
residential aftercare reported a range of positive 
outcomes.53  
Compared with people in prison randomised to 
routine mental health treatment, participation in 
modified therapeutic communities was associated 
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with greater reductions in alcohol and drug use at one year after release and significantly 
reduced rates of re-imprisonment.53 
All participants had both a serious mental disorder and an alcohol and other drug use disorder 
(32% used drugs, 32% used alcohol).  
Modified therapeutic communities commonly retain the key structures, elements and processes 
of a traditional therapeutic community approach and adapt the model to better address the 
needs of specific groups, and in this case those with co-occurring mental health and alcohol and 
other drug disorders. 
Modifications can include less confrontational therapeutic styles, greater flexibility in treatment 
phases, more individualised treatment, and employment of more professional staff, including 
doctors, psychiatrists, and counsellors with postgraduate training.114, 115 
Other helpful modifications included incorporation of a CBT curriculum that emphasised criminal 
thinking and behaviour and psychoeducational classes regarding the interrelationship of mental 
illness, alcohol and other drug use, and criminality.115 
One study showed motivational interviewing among imprisoned adolescents with depressed 
mood and recent alcohol and other drug use was effective in reducing marijuana use and to 
some degree alcohol use, compared with relaxation training.84, 116 
Integrated dual diagnosis treatment programs following an in-custody treatment unit 
demonstrated increased use of outpatient medication services and reduced average days of 
hospitalisation over 18 months compared with treatment as usual on release from the unit. No 
relevant drug or crime outcome measures over time were reported.53 
For men with co-occurring amphetamine dependence and attention deficit hyperactivity disorder 
(ADHD), medication with slow release methylphenidate commenced two weeks prior to release 
from prison and continued in conjunction with outpatient CBT. This combination showed greater 





Young adults comprise a significant part of the adult prison population. In Victoria, around half of 
all young offenders aged between 18 and 21 given a custodial sentence were sentenced to an 
adult prison.117 
Young offenders between 18 and 21 years are commonly given less severe sentences than adult 
offenders. It is recognised that their immaturity and inexperience may make them less culpable, 
and that rehabilitation should be the focus.117 However, there is limited specific evidence and 
programming for young adult offenders, with most research focused on juvenile and adolescent 
offenders aged under 18 years.  
Young people engaged with Victorian specialist alcohol and other drug services in the 
community have been found to have extremely high levels of harmful alcohol and other drug use 
and complex psychosocial needs, with two thirds of treatment clients having criminal justice 
involvement.118 
Prison entrant data collected in 2015 showed that prison entrants aged 18-24 years were the 
most likely to have used illicit drugs within the past 12 months (76%). The most common illicit 
drugs used were methamphetamine (59%) and cannabis (53%).119 
Offenders in Victoria aged 25 years and under have an increased likelihood of recidivism, with 
earlier research indicating younger offenders may also have a shorter time to re-offending than 
older counterparts.120 
As with the literature for alcohol and other drug use treatment more broadly, evaluations of 
alcohol and other drug treatment programs for people in prison in the US  and Australia have 
found that younger age is associated with greater treatment drop-out. 14,66 
The literature emphasises the need to successfully engage younger people in prison in treatment 
and provide support for complex needs such as social skills and community integration, mental 
health and education. 
Research into effective treatment for younger offenders is primarily focused on juvenile and 
adolescent populations. There is little quality evidence to guide treatment for young adults. 
However, more preparatory work and motivational approaches may be of benefit.66 
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From the juvenile offender literature, which can extend to studies involving offenders aged 18-19 
years, counselling interventions, provision of multiple services and skills building are effective 
approaches to decrease juvenile recidivism, while tailored treatment models that include family 
show promise for reducing alcohol and other drug use.121 
While not solely alcohol and other drug focused, positive outcomes of a multi-service and tailored 
approach are evident from the evaluation of Victoria’s specialist 35-bed youth unit within Port 
Phillip Prison for people in prison aged 18 to 25 years.  
The unit provides youth specific programs and support covering education, offending behaviour, 
personal development, leisure and recreation and employment, and includes alcohol and other 
drug programs. 
People in prison placed in the unit for 60 days or more had lower recidivism rates compared to 
the comparison groups (32.5% vs 41%). They also reported the unit was a safer environment, was 
viewed more positively by individuals, and had a greater rehabilitation focus than two mainstream 
comparison groups.117 
However, when confounding variables are statistically controlled in analyses, relatively few 
differences are found in the effectiveness of different types of therapeutic interventions for 
juvenile offenders.122  
Three factors were identified as major predictors of program effectiveness: a ‘therapeutic’ 
intervention philosophy; serving high risk offenders; and quality of implementation. 
A meta-analysis showed that aftercare programs for young adult and juvenile offenders released 
from correctional institutions had a small effect on recidivism, with more intensive programs 
associated with lower rates of rearrests and reconvictions.123 
Greater effect was found for aftercare programs that were well implemented (as opposed to 
those programs that described implementation difficulties), consisted of individual rather than 
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group treatment, and were aimed at older and ‘high-risk’ youth. 
Program initiation (pre- or post- release) and program duration 
showed no effects. 
People from culturally and linguistically 
diverse backgrounds 
In June 2014, Victoria had the highest proportion of people in 
prison born overseas (25%), with nearly 20 per cent having 
English as their second language.124 
Despite growing numbers of people in prison from diverse 
cultural and linguistic backgrounds, very little is known about 
what works in prison-based alcohol and other drug treatment 
for these populations.  
In a survey on help seeking among people in prison in the 
United Kingdom, over half  those whose first language was not 
English reported they would not seek help for alcohol and 
other drug problems - twice as many as native English 
speakers.125 
Language and other cultural factors are significant barriers for 
help seeking and treatment engagement for people in 
prison,125 suggesting that prison based alcohol and other drug 
programs must be culturally informed, and use materials that 
can be read and understood by participants. 
There is limited evidence to guide effective engagement and 
response strategies with people in prison from diverse cultural 
backgrounds, and mixed findings regarding efficacy of 
treatment across cultural groups. Some interventions such as 
counselling programs, have been shown to be effective in 
reducing re-offending across ethnic and racial groups.86 
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People with acquired brain injury 
Acquired brain injury (ABI) among people in Australian prisons is significant, with over one third of 
prison entrants at increased risk of ABI as indicated by whether they had ever received a blow to 
the head that resulted in a loss of consciousness.119 
In a cohort experiencing high rates of mental health and alcohol and other drug use disorders, it 
is also expected that a significant minority of prisoners will have varying levels of alcohol related 
brain damage (ARBD).126 
Information concerning the most effective alcohol and other drug treatment response for this 
group is lacking, and importantly, treatment outcome studies on which best practice is based 
usually excludes participants with ABI due to impairment. 
A report by the UK Royal College of Psychiatrists reviewed the literature relating to ARBD, 
including among prisoner populations.126 
The close association between ARBD and traumatic brain injury was noted and screening for 
both was recommended. The report indicated that for prisoners with ARBD, a considerable 
proportion of these individuals will improve through abstinence. 
It is recommended that alcohol misuse screening instruments are routinely used on admission to 
prison to identify people at risk of ARBD. Reassessments should then be made once individuals 
have settled into routine prison life and are referred to appropriate external services on release. 
The report found that people in prison who have significant deficits due to ARBD may be unable 
to engage well with CBT treatment programs, which could impede their progress towards 
gaining release.126 
Recommendations for screening and management of ARBD within the UK prison service were:  
• Alcohol withdrawal may need to be conducted under care of the local hospital. 
• Primary and secondary screening should incorporate alcohol screening instruments. 
• Individuals identified as having alcohol-related problems should be signposted to appropriate 
support facilities.  
• People with alcohol-related problems should be reassessed prior to release from prison and 
referred to appropriate external agencies. 
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People with low literacy 
Education levels among prisoner populations are commonly lower than in the general population. 
Higher levels of schooling are associated with a lower probability of arrest and imprisonment.119 
While it is clear that alcohol and other drug treatment interventions need to be accessible and 
appropriate for a wide range of reading and comprehension levels, there is limited research 
about best practice alcohol and other drug treatment specific to people in prison with low literacy. 
A 2010 evaluation of the correctional centre in Canberra highlighted concerns that treatment 
programs may not adequately cater to those with low literacy levels, and interventions requiring 
homework and reflection on ideas considered ‘text-book stuff’ could be a barrier to treatment 
engagement for some people in prison.127 
Participant criteria for the Getting SMART program, a widely used CBT-based intervention in 
NSW prisons, requires a ‘reading level 2’ and ‘writing level 1’ based on the Australian Core Skills 
Framework (ACSF) literacy level.66 
Only three of the fifty-nine program participants who dropped out of the program reported doing 
so due to inadequate literacy.66 
The implications for alcohol and other drug program practice are to assess the literacy levels of 
all participants and ensure that the reading materials and handouts are set at an appropriate 
literacy level. 
People in prison who have low literacy can and should be encouraged to participate in alcohol 
and other drug group programs, and group facilitators should check participants’ understanding 
of the materials at the end of each session and adjust as necessary. 
For some, it may require specially developed handouts with graphics rather than words, or an 
additional individual session to explain the materials, especially when CBT practice tasks or 
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